Pharmacy Times®
Specialty Pharmacy Times
Cancer, Hepatitis C Drugs Loom Large in Specialty Pipeline
Davy James, Associate Editor
Express Scripts Senior Clinical Consultant Aimee Tharaldson, PharmD, discusses specialty pharmacy treatment options for 2014 and beyond.
NASP Leader Discusses Changing Specialty Pharmacy Landscape
Davy James, Associate Editor
In an interview with Specialty Pharmacy Times, James E. Smeeding, executive director of the National Association of Specialty Pharmacy, discusses the organization’s future and issues in the specialty marketplace.
Nilotinib Therapy May Be More Likely to Produce Major Molecular Response in Chronic Myeloid Leukemia Patients
Eileen Oldfield, Associate Editor
Newly diagnosed chronic myeloid leukemia patients may be more likely to achieve major molecular response if they receive nilotinib therapy, a new study suggests.
COSMOS Hepatitis C Trial Results Announced
Michael R. Page, PharmD, RPh
In a phase II trial, combination treatment with simeprevir and sofosbuvir yields functional cure rates exceeding 90% in patients receiving 12 weeks of therapy—even among difficult-to-treat patients.
Otezla by Celgene
Michael R. Page, PharmD, RPh
Michael R. Page earned his PharmD from the Ernest Mario School of Pharmacy at Rutgers University. He has worked as a community pharmacist at CVS Pharmacy and is currently clinical editor in clinical and scientific affairs at Pharmacy Times.
Genentech’s Gazyva for Chronic Lymphocytic Leukemia
Michael R. Page, PharmD, RPh
In late 2013, the FDA granted Genentech, Inc’s, Gazyva (obinutuzumab) approval as a breakthrough-designated therapy for chronic lymphocytic leukemia. Gazyva is the first such treatment approved under the FDA’s accelerated-approval program.
Featured Video
Promoting Patient Adherence
Suzanne Tschida, PharmD, BCPS, vice president of specialty benefit and outcomes strategy at OptumRx, talks about promoting patient adherence.
Industry Guide
We've created this Industry Guide with close to 300 companies and organizations as a one-stop guide for industry stakeholders in the specialty pharmacy space.
Current Issue
Volume: 5
Number: 1
Conference Calendar
â—„        April 2014        â–º
Featured Company Profile
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Pharmacy Times 2006-2013
Intellisphere, LLC. All Rights Reserved.